Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the 1-year efficacy and safety of the fixed combination beclometasone/formoterol
pMDI in a twice daily regimen in patients with stable severe COPD.